Clinical Trials

Inclusion Criteria:

• Post-lingually deafened adults (age ≥ 18 years).
• < 10 years duration of deafness.
• Likely to meet audiologic candidacy criteria for cochlear implant (CI) (based on screening of audiologic testing performed locally).
• Normal inner ear anatomy.
• Access to appropriate technology (computer, tablet or mobile phone) for videoconference.
• All patients who do not require prior written authorization from their insurers for this procedure.

Exclusion Criteria:

• Individuals < 18 years of age.
• Comorbidities or cognitive deficits that prevent participation in the telehealth component and preference for non-Cochlear brand devices, non-English speaking, or deafness caused by pathology that would significantly impact outcomes such as significant head trauma, certain brain tumors, revision CI. Those patients who continue to undergo CI through the traditional care delivery model will serve as the “control” group for comparison purposes. 
• Additional exclusion criteria for the traditional control group include non-English speaking, a revision CI, deafness due to a tumor, single-sided deafness, or any patients that have a cause of hearing loss that the study staff consider “non-traditional”, as this would not be a good patient to compare to the subjects in the other study arm.

Eligibility last updated 9/3/21. Questions regarding updates should be directed to the study team contact.